2 false false false false false false false false false true false false false false false false No description of principal activity 2022-10-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 11555613 2022-10-01 2023-09-30 11555613 2023-09-30 11555613 2021-10-01 2022-09-30 11555613 2022-09-30 11555613 bus:Director1 2022-10-01 2023-09-30 11555613 core:WithinOneYear 2023-09-30 11555613 core:WithinOneYear 2022-09-30 11555613 core:RestatedAmount 2022-09-30 11555613 bus:Micro-entities 2022-10-01 2023-09-30 11555613 bus:AuditExemptWithAccountantsReport 2022-10-01 2023-09-30 11555613 bus:FullAccounts 2022-10-01 2023-09-30 11555613 bus:SmallCompaniesRegimeForAccounts 2022-10-01 2023-09-30 11555613 bus:PrivateLimitedCompanyLtd 2022-10-01 2023-09-30
COMPANY REGISTRATION NUMBER: 11555613
BNL Pharma Solutions Ltd
Filleted Unaudited Financial Statements
For the period ended
30 September 2023
BNL Pharma Solutions Ltd
Statement of Financial Position
30 September 2023
2023
2022
£
£
Fixed assets
2,837
3,783
-------
-------
Current assets
37,541
29,839
Creditors: amounts falling due within one year
28,012
42,625
--------
--------
Net current assets/(liabilities)
9,529
( 12,786)
--------
--------
Total assets less current liabilities
12,366
( 9,003)
Accruals and deferred income
17,034
--------
-------
(4,668)
(9,003)
--------
-------
Capital and reserves
( 4,668)
( 9,003)
-------
-------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2022: 2 ).
2. Directors' advances, credits and guarantees
Included in other creditors is £1,624 (2022: £312) owed to the director.
For the year ending 30 September 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 7 November 2023 , and are signed on behalf of the board by:
Mr J Harker
Director
Company registration number: 11555613
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is The Whitehouse, Denchworth Road, Grove, Wantage, Oxfordshire, OX12 0AR.